Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference

11/17/2021 | 10:01am EST

INDIANAPOLIS, Nov. 17, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the fourth annual Evercore ISI HealthCONx Conference on Tuesday, Nov. 30, 2021. Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific and medical officer, and president of Lilly Research Laboratories, will participate in a fireside chat at 12:10 p.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Eli Lilly and Company  
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Refer to:

Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)


Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)    

 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-fourth-annual-evercore-isi-healthconx-conference-301424446.html

SOURCE Eli Lilly and Company


ę PRNewswire 2021
All news about ELI LILLY AND COMPANY
01/14Pieris Doses First Patient in Phase 2 Gastric Cancer Trial of Cinrebafusp Alfa
MT
01/14WHO recommendation on Merck's oral pill likely in early February
RE
01/13GSK-Vir, Eli Lilly's COVID-19 Treatments Recommended by WHO
MT
01/13WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool
RE
01/12Biogen shares slide as Medicare proposal restricts coverage of Alzheimer's treatments
RE
01/06Lilly to Participate in the J.P. Morgan Healthcare Conference
PR
01/06Eli Lilly Sets Neurology Collaboration With Entos Pharmaceuticals
DJ
01/06Eli Lilly, Entos Pharmaceuticals Partner To Develop Therapies For Multiple Neurologic I..
MT
01/06Eli Lilly, Entos to Jointly Develop Therapies for Multiple Neurologic Indications
MT
01/06Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement to Supp..
PR
More news
Analyst Recommendations on ELI LILLY AND COMPANY
More recommendations